📰 Amgen News
Page 94 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
March 31, 2024
Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
March 31, 2024
BLB&B Advisors LLC lifted its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.9% during the fourth quarter, HoldingsChannel.com reports. The firm owned 3,889 shares of the medical research company’s stock after purchasing an additional 111 shares during the period. BLB&B Advisors LLC’s holdings in Amgen were worth $1,120,000 as of its most recent […]
March 31, 2024
Scientists are finding that anti-obesity medicines can also help treat dozens of other diseases | Science & technology
March 29, 2024
After a Colorado board that reviews prescription drug prices deemed the medicine Enbrel unaffordable, the arthritis drug's maker filed a lawsuit.
March 29, 2024
Plus, Novo Nordisk's $1 billion bet, and Moderna looks beyond the COVID vaccine,
March 29, 2024
Shares of Viking Therapeutics have skyrocketed more than 350% this year.
March 29, 2024
Saxon Interests Inc. purchased a new stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,652 shares of the medical research company’s stock, valued at approximately $476,000. Several other large […]
March 29, 2024
Relyea Zuckerberg Hanson LLC boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 42.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,345 shares of the medical research company’s stock after purchasing an additional 399 shares during the period. […]
March 29, 2024
The 101 Biotech Corridor has sprung up over the past quarter century in the region around biotech giant Amgen Inc.’s Thousand Oaks headquarters.
March 29, 2024
Franklin Street Advisors Inc. NC raised its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 47,084 shares of the medical research company’s stock after buying an additional 4,101 shares during the […]